Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Oxonica is in cosmetics and detection deals
January 9, 2006
| A version of this story appeared in
Volume 84, Issue 2
Nanotechnology specialist Oxonica has signed a deal under which specialty chemical producer Croda will distribute its Optisol UV absorber to the personal care market. Optisol was launched in 2004 and is used by one U.K. firm in facial care products. Oxonica says the partnership with Croda is geared toward cultivating other customers. Meanwhile, Oxonica has agreed to acquire U.S.-based Nanoplex Technologies for shares in Oxonica equivalent to approximately 17% of the enlarged company. Nanoplex specializes in nanoparticle-based detection systems for health care and security.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X